Pharmaceuticals to provide safe needle collection and disposal programs for patients

It is illegal in the state of California to unsafely dispose of "sharps" (medical waste such as needles and syringes) in the home, and thanks to California State Senator Joe Simitian's Senate Bill 486, and contributors from his annual "There Oughta Be A Law" contest, 1 million Californians will not be breaking the law anymore (see http://www.ciwmb.ca.gov/hhw/sharps/).

American Scientific Resources, Inc. (Pink Sheets: ASFX) (the Company), is pleased to note that the SB 486 has been approved by Governor Schwarzenegger, providing Californians with a safe way to dispose of their sharps at home. Approximately 386-million sharps are generated each year in California that need to be disposed of (source).

This new law will require pharmaceutical companies to submit plans to the California Integrated Waste Management Board on how they propose to support the patients who use their drugs by providing safe needle collection and disposal programs. Additionally, they will be required to provide the specialty medication users (such as those with multiple sclerosis, diabetes, rheumatoid arthritis, hepatitis and HIV) with information on their websites on the various product options available to safely and easily manage their sharps.

Jason Roth, ASR's Senior Vice President comments, "Not only is this a triumph for numerous Californians, but it is also creating corporate responsibility in the green movement and holding pharmaceutical companies accountable for the proper disposal of their patients safe needle disposal. ASR is very much looking forward to continuing discussions with the pharmaceutical manufacturers about how we can meet their needs in the US and the rest of the globe."

ASR manufacturers the world's only FDA approved home needle destruction device (NDD), the Disintegrator(TM) and Disintegrator Plus(TM). The Disintegrator enables patients who give themselves injections to properly and safely dispose of needles at home.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study focuses on COPD progression in younger populations